News

Not many stocks are truly capable of generating a 1,000% return on investment within a reasonable time frame. Even so, a fair number of next-generation technology stocks have hit this lofty

Buying a soaring growth stock can be both exciting and risky territory for investors. In the biotech world, all it often takes is news of an approval from the Food and Drug Administration (FDA) or

You can secure a 5% dividend yield without being too risky or aggressive. Sometimes, it's a matter of jumping on a good opportunity when it arises. A stock can fall in value for various reasons

You can secure a 5% dividend yield without being too risky or aggressive. Sometimes, it's a matter of jumping on a good opportunity when it arises. A stock can fall in value for various reasons

Artificial intelligence (AI) has taken center stage in recent times. Some see it as the next technology to transform the world.

We've already gotten a taste of some of its power. Amazon uses AI to

Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products

Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products

Most smaller biotech companies would love to follow in the footsteps of Vertex Pharmaceuticals (NASDAQ: VRTX). The company is the global leader in cystic fibrosis (CF) treatments. And these products

The market has been showing signs of life this year, but the S&P 500 remains down 10% since peaking in 2022. In a full-blown bull market, many businesses could see their valuations skyrocket

The market has been showing signs of life this year, but the S&P 500 remains down 10% since peaking in 2022. In a full-blown bull market, many businesses could see their valuations skyrocket

Dividend stocks can make for great investments as they can be excellent sources of recurring income for your portfolio. And with dividend growth stocks, there's also a strong possibility that the

For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter It's completely free and we guarantee you'll learn something new every day.

The war on drug

Shares of NovoCure (NASDAQ: NVCR) were crashing 29.6% lower as of 10:19 a.m. ET on Tuesday. The steep decline came after the company announced data for its Tumor Treating Fields (TTFields) therapy

Shares of HealthEquity (NASDAQ: HQY) were up more than 13% Tuesday morning after the healthcare services company reported earnings after the markets closed on Monday. The stock is up more than 9% so

One of the exciting parts of investing is identifying companies that will offer us the next big thing. This could be a game-changing drug or an exciting technology that may transform healthcare. And

Shares of home healthcare solutions company Amedisys (NASDAQ: AMED) were up more than 14% Monday morning after the company reported that it had received an unsolicited buyout offer from Optum, a

Dividend Kings are among the most steady corporations on the market. While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least